Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Journal article

Pouwels KB. et al, (2021), Nature Medicine, 27, 2127 - 2135

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Journal article

Payne RP. et al, (2021), Cell, 184, 5699 - 5714.e11

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Journal article

Wei J. et al, (2021), Nature Communications, 12

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

Journal article

Eyre DW. et al, (2021), Clinical Microbiology and Infection, 27, 1516.e7 - 1516.e14

Cuts to UK official development assistance budget jeopardise global viral hepatitis elimination goals.

Journal article

Lemoine M. et al, (2021), The lancet. Gastroenterology & hepatology, 6, 527 - 528

Equity for excellence in academic institutions: a manifesto for change

Journal article

Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection

Journal article

Downs LO. et al, (2021), Wellcome Open Research, 5, 240 - 240

Equity for excellence in academic institutions: a manifesto for change.

Journal article

Wedekind L. et al, (2021), Wellcome open research, 6

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Journal article

Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400

Load More